Global Malignant Glioma Market Research Report 2023

Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers.

The global Malignant Glioma market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and prevalence cases, followed by Europe where the major pharmaceuticals have their blockbuster drugs and include the major funding associations.

This report aims to provide a comprehensive presentation of the global market for Malignant Glioma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Malignant Glioma.

The Malignant Glioma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Malignant Glioma market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Malignant Glioma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Malignant Glioma Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 ChemOthersapy

1.2.3 Drugs

1.3 Market by Application

1.3.1 Global Malignant Glioma Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Cancer Research Organizations

1.3.4 Diagnostic Centers

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Malignant Glioma Market Perspective (2018-2029)

2.2 Malignant Glioma Growth Trends by Region

2.2.1 Global Malignant Glioma Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Malignant Glioma Historic Market Size by Region (2018-2023)

2.2.3 Malignant Glioma Forecasted Market Size by Region (2024-2029)

2.3 Malignant Glioma Market Dynamics

2.3.1 Malignant Glioma Industry Trends

2.3.2 Malignant Glioma Market Drivers

2.3.3 Malignant Glioma Market Challenges

2.3.4 Malignant Glioma Market Restraints

3.1 Global Top Malignant Glioma Players by Revenue

3.1.1 Global Top Malignant Glioma Players by Revenue (2018-2023)

3.1.2 Global Malignant Glioma Revenue Market Share by Players (2018-2023)

3.2 Global Malignant Glioma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Malignant Glioma Revenue

3.4 Global Malignant Glioma Market Concentration Ratio

3.4.1 Global Malignant Glioma Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Malignant Glioma Revenue in 2022

3.5 Malignant Glioma Key Players Head office and Area Served

3.6 Key Players Malignant Glioma Product Solution and Service

3.7 Date of Enter into Malignant Glioma Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Malignant Glioma Historic Market Size by Type (2018-2023)

4.2 Global Malignant Glioma Forecasted Market Size by Type (2024-2029)

5.1 Global Malignant Glioma Historic Market Size by Application (2018-2023)

5.2 Global Malignant Glioma Forecasted Market Size by Application (2024-2029)

6.1 North America Malignant Glioma Market Size (2018-2029)

6.2 North America Malignant Glioma Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Malignant Glioma Market Size by Country (2018-2023)

6.4 North America Malignant Glioma Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Malignant Glioma Market Size (2018-2029)

7.2 Europe Malignant Glioma Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Malignant Glioma Market Size by Country (2018-2023)

7.4 Europe Malignant Glioma Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Malignant Glioma Market Size (2018-2029)

8.2 Asia-Pacific Malignant Glioma Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Malignant Glioma Market Size by Region (2018-2023)

8.4 Asia-Pacific Malignant Glioma Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Malignant Glioma Market Size (2018-2029)

9.2 Latin America Malignant Glioma Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Malignant Glioma Market Size by Country (2018-2023)

9.4 Latin America Malignant Glioma Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Malignant Glioma Market Size (2018-2029)

10.2 Middle East & Africa Malignant Glioma Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Malignant Glioma Market Size by Country (2018-2023)

10.4 Middle East & Africa Malignant Glioma Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Merck

11.1.1 Merck Company Detail

11.1.2 Merck Business Overview

11.1.3 Merck Malignant Glioma Introduction

11.1.4 Merck Revenue in Malignant Glioma Business (2018-2023)

11.1.5 Merck Recent Development

11.2 Eli Lilly

11.2.1 Eli Lilly Company Detail

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Malignant Glioma Introduction

11.2.4 Eli Lilly Revenue in Malignant Glioma Business (2018-2023)

11.2.5 Eli Lilly Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Detail

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Malignant Glioma Introduction

11.3.4 AbbVie Revenue in Malignant Glioma Business (2018-2023)

11.3.5 AbbVie Recent Development

11.4 Bristol-Myers Squibb

11.4.1 Bristol-Myers Squibb Company Detail

11.4.2 Bristol-Myers Squibb Business Overview

11.4.3 Bristol-Myers Squibb Malignant Glioma Introduction

11.4.4 Bristol-Myers Squibb Revenue in Malignant Glioma Business (2018-2023)

11.4.5 Bristol-Myers Squibb Recent Development

11.5 Genentech

11.5.1 Genentech Company Detail

11.5.2 Genentech Business Overview

11.5.3 Genentech Malignant Glioma Introduction

11.5.4 Genentech Revenue in Malignant Glioma Business (2018-2023)

11.5.5 Genentech Recent Development

11.6 Sun Pharmaceutical

11.6.1 Sun Pharmaceutical Company Detail

11.6.2 Sun Pharmaceutical Business Overview

11.6.3 Sun Pharmaceutical Malignant Glioma Introduction

11.6.4 Sun Pharmaceutical Revenue in Malignant Glioma Business (2018-2023)

11.6.5 Sun Pharmaceutical Recent Development

11.7 BioMimetix

11.7.1 BioMimetix Company Detail

11.7.2 BioMimetix Business Overview

11.7.3 BioMimetix Malignant Glioma Introduction

11.7.4 BioMimetix Revenue in Malignant Glioma Business (2018-2023)

11.7.5 BioMimetix Recent Development

11.8 Cipla

11.8.1 Cipla Company Detail

11.8.2 Cipla Business Overview

11.8.3 Cipla Malignant Glioma Introduction

11.8.4 Cipla Revenue in Malignant Glioma Business (2018-2023)

11.8.5 Cipla Recent Development

11.9 Sigma-Aldrich

11.9.1 Sigma-Aldrich Company Detail

11.9.2 Sigma-Aldrich Business Overview

11.9.3 Sigma-Aldrich Malignant Glioma Introduction

11.9.4 Sigma-Aldrich Revenue in Malignant Glioma Business (2018-2023)

11.9.5 Sigma-Aldrich Recent Development

11.10 Panacea Biotec

11.10.1 Panacea Biotec Company Detail

11.10.2 Panacea Biotec Business Overview

11.10.3 Panacea Biotec Malignant Glioma Introduction

11.10.4 Panacea Biotec Revenue in Malignant Glioma Business (2018-2023)

11.10.5 Panacea Biotec Recent Development

11.11 Zydus Cadila

11.11.1 Zydus Cadila Company Detail

11.11.2 Zydus Cadila Business Overview

11.11.3 Zydus Cadila Malignant Glioma Introduction

11.11.4 Zydus Cadila Revenue in Malignant Glioma Business (2018-2023)

11.11.5 Zydus Cadila Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Malignant Glioma Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of ChemOthersapy

    Table 3. Key Players of Drugs

    Table 4. Global Malignant Glioma Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Malignant Glioma Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Malignant Glioma Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Malignant Glioma Market Share by Region (2018-2023)

    Table 8. Global Malignant Glioma Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Malignant Glioma Market Share by Region (2024-2029)

    Table 10. Malignant Glioma Market Trends

    Table 11. Malignant Glioma Market Drivers

    Table 12. Malignant Glioma Market Challenges

    Table 13. Malignant Glioma Market Restraints

    Table 14. Global Malignant Glioma Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Malignant Glioma Market Share by Players (2018-2023)

    Table 16. Global Top Malignant Glioma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malignant Glioma as of 2022)

    Table 17. Ranking of Global Top Malignant Glioma Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Malignant Glioma Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Malignant Glioma Product Solution and Service

    Table 21. Date of Enter into Malignant Glioma Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Malignant Glioma Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Malignant Glioma Revenue Market Share by Type (2018-2023)

    Table 25. Global Malignant Glioma Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Malignant Glioma Revenue Market Share by Type (2024-2029)

    Table 27. Global Malignant Glioma Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Malignant Glioma Revenue Market Share by Application (2018-2023)

    Table 29. Global Malignant Glioma Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Malignant Glioma Revenue Market Share by Application (2024-2029)

    Table 31. North America Malignant Glioma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Malignant Glioma Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Malignant Glioma Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Malignant Glioma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Malignant Glioma Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Malignant Glioma Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Malignant Glioma Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Malignant Glioma Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Malignant Glioma Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Malignant Glioma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Malignant Glioma Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Malignant Glioma Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Malignant Glioma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Malignant Glioma Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Malignant Glioma Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Merck Company Detail

    Table 47. Merck Business Overview

    Table 48. Merck Malignant Glioma Product

    Table 49. Merck Revenue in Malignant Glioma Business (2018-2023) & (US$ Million)

    Table 50. Merck Recent Development

    Table 51. Eli Lilly Company Detail

    Table 52. Eli Lilly Business Overview

    Table 53. Eli Lilly Malignant Glioma Product

    Table 54. Eli Lilly Revenue in Malignant Glioma Business (2018-2023) & (US$ Million)

    Table 55. Eli Lilly Recent Development

    Table 56. AbbVie Company Detail

    Table 57. AbbVie Business Overview

    Table 58. AbbVie Malignant Glioma Product

    Table 59. AbbVie Revenue in Malignant Glioma Business (2018-2023) & (US$ Million)

    Table 60. AbbVie Recent Development

    Table 61. Bristol-Myers Squibb Company Detail

    Table 62. Bristol-Myers Squibb Business Overview

    Table 63. Bristol-Myers Squibb Malignant Glioma Product

    Table 64. Bristol-Myers Squibb Revenue in Malignant Glioma Business (2018-2023) & (US$ Million)

    Table 65. Bristol-Myers Squibb Recent Development

    Table 66. Genentech Company Detail

    Table 67. Genentech Business Overview

    Table 68. Genentech Malignant Glioma Product

    Table 69. Genentech Revenue in Malignant Glioma Business (2018-2023) & (US$ Million)

    Table 70. Genentech Recent Development

    Table 71. Sun Pharmaceutical Company Detail

    Table 72. Sun Pharmaceutical Business Overview

    Table 73. Sun Pharmaceutical Malignant Glioma Product

    Table 74. Sun Pharmaceutical Revenue in Malignant Glioma Business (2018-2023) & (US$ Million)

    Table 75. Sun Pharmaceutical Recent Development

    Table 76. BioMimetix Company Detail

    Table 77. BioMimetix Business Overview

    Table 78. BioMimetix Malignant Glioma Product

    Table 79. BioMimetix Revenue in Malignant Glioma Business (2018-2023) & (US$ Million)

    Table 80. BioMimetix Recent Development

    Table 81. Cipla Company Detail

    Table 82. Cipla Business Overview

    Table 83. Cipla Malignant Glioma Product

    Table 84. Cipla Revenue in Malignant Glioma Business (2018-2023) & (US$ Million)

    Table 85. Cipla Recent Development

    Table 86. Sigma-Aldrich Company Detail

    Table 87. Sigma-Aldrich Business Overview

    Table 88. Sigma-Aldrich Malignant Glioma Product

    Table 89. Sigma-Aldrich Revenue in Malignant Glioma Business (2018-2023) & (US$ Million)

    Table 90. Sigma-Aldrich Recent Development

    Table 91. Panacea Biotec Company Detail

    Table 92. Panacea Biotec Business Overview

    Table 93. Panacea Biotec Malignant Glioma Product

    Table 94. Panacea Biotec Revenue in Malignant Glioma Business (2018-2023) & (US$ Million)

    Table 95. Panacea Biotec Recent Development

    Table 96. Zydus Cadila Company Detail

    Table 97. Zydus Cadila Business Overview

    Table 98. Zydus Cadila Malignant Glioma Product

    Table 99. Zydus Cadila Revenue in Malignant Glioma Business (2018-2023) & (US$ Million)

    Table 100. Zydus Cadila Recent Development

    Table 101. Research Programs/Design for This Report

    Table 102. Key Data Information from Secondary Sources

    Table 103. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Malignant Glioma Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Malignant Glioma Market Share by Type: 2022 VS 2029

    Figure 3. ChemOthersapy Features

    Figure 4. Drugs Features

    Figure 5. Global Malignant Glioma Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Malignant Glioma Market Share by Application: 2022 VS 2029

    Figure 7. Hospitals Case Studies

    Figure 8. Cancer Research Organizations Case Studies

    Figure 9. Diagnostic Centers Case Studies

    Figure 10. Others Case Studies

    Figure 11. Malignant Glioma Report Years Considered

    Figure 12. Global Malignant Glioma Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Malignant Glioma Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Malignant Glioma Market Share by Region: 2022 VS 2029

    Figure 15. Global Malignant Glioma Market Share by Players in 2022

    Figure 16. Global Top Malignant Glioma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malignant Glioma as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Malignant Glioma Revenue in 2022

    Figure 18. North America Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Malignant Glioma Market Share by Country (2018-2029)

    Figure 20. United States Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Malignant Glioma Market Share by Country (2018-2029)

    Figure 24. Germany Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Malignant Glioma Market Share by Region (2018-2029)

    Figure 32. China Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Malignant Glioma Market Share by Country (2018-2029)

    Figure 40. Mexico Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Malignant Glioma Market Share by Country (2018-2029)

    Figure 44. Turkey Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Malignant Glioma Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Merck Revenue Growth Rate in Malignant Glioma Business (2018-2023)

    Figure 47. Eli Lilly Revenue Growth Rate in Malignant Glioma Business (2018-2023)

    Figure 48. AbbVie Revenue Growth Rate in Malignant Glioma Business (2018-2023)

    Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Malignant Glioma Business (2018-2023)

    Figure 50. Genentech Revenue Growth Rate in Malignant Glioma Business (2018-2023)

    Figure 51. Sun Pharmaceutical Revenue Growth Rate in Malignant Glioma Business (2018-2023)

    Figure 52. BioMimetix Revenue Growth Rate in Malignant Glioma Business (2018-2023)

    Figure 53. Cipla Revenue Growth Rate in Malignant Glioma Business (2018-2023)

    Figure 54. Sigma-Aldrich Revenue Growth Rate in Malignant Glioma Business (2018-2023)

    Figure 55. Panacea Biotec Revenue Growth Rate in Malignant Glioma Business (2018-2023)

    Figure 56. Zydus Cadila Revenue Growth Rate in Malignant Glioma Business (2018-2023)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed